Treace(US:TMCI) Prnewswireยท2025-05-16 09:45Core Viewpoint - A class action securities lawsuit has been filed against Treace Medical Concepts, Inc. due to alleged securities fraud impacting investors between May 8, 2023, and May 7, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Treace Medical Concepts made false statements regarding the demand for its primary product, the 3D bunion correction system, "Lapiplasty," which was affected by competition [2]. - It is alleged that the company's revenue declined, prompting the need to accelerate plans for an alternative product to osteotomy [2]. - The defendants' positive statements about the company's business and prospects were reportedly misleading and lacked a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 10, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].